Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000335 · ClinicalTrials.gov registry record · Phase 2
Activity Monitoring Assessment of Opiate Withdrawal - 4
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000335 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA).
The verdict
NCT00000335, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate these symptoms.
Interventions
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1995-09-30 |
| Est. Completion | 1996-05-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000335
The ClinicalTrials.gov registry entry for NCT00000335 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Morphine is the first listed.
NCT00000335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000335 about?
NCT00000335 is a clinical study titled "Activity Monitoring Assessment of Opiate Withdrawal - 4". The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdraw...
What is the current status of trial NCT00000335?
This trial is currently completed. It is a Phase 2 study. The study started on 1995-09-30. Estimated completion is 1996-05-20.
What interventions are being tested in trial NCT00000335?
The interventions under investigation include: Morphine (DRUG).
Who is sponsoring clinical trial NCT00000335?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.